Why are Dr. Gordon Moore and Mr. James Denny retiring?

Dr. Moore and Mr. Denny have announced their intention to retire from the Board of Directors at the end of their current terms in May 2013. The company has stated that these retirements are not due to any disputes or disagreements with Gilead Sciences.

Will Mr. James Denny continue to be involved with Gilead after his retirement?

Mr. Denny will continue to serve as the Company's Lead Independent Director until his retirement from the Board in May 2013. After May 2013, his role on the Board will cease.

What is the significance of the Lead Independent Director role?

The Lead Independent Director plays a crucial role in corporate governance, particularly in board leadership, independent oversight, and ensuring accountability. The appointment of a successor will be important for maintaining effective independent governance.

Are there any immediate financial implications from these board retirements?

This 8-K filing solely concerns the retirement of two board members. There are no immediate financial implications or changes to Gilead's financial performance or operations directly stated in this filing.

GILD 8-K: Leadership Changes

Summary

Gilead Sciences, Inc. (GILD) announced a change in its Board of Directors on January 30, 2013, with the upcoming retirements of Dr. Gordon Moore and Mr. James Denny. Both directors plan to retire at the end of their current terms in May 2013. This transition is noteworthy as it involves the departure of two long-standing board members, including the Lead Independent Director. Importantly, the company stated that these retirements are not due to any disputes or disagreements with Gilead. Mr. Denny will continue in his role as Lead Independent Director until his retirement, with a successor to be appointed in May 2013. Investors should monitor the composition of the board following these changes and the selection of a new Lead Independent Director to understand any potential shifts in governance or strategic oversight.

Key Highlights

1Dr. Gordon Moore and Mr. James Denny to retire from the Board of Directors in May 2013.
2Retirements are effective at the end of their current terms.
3Departures are not a result of any dispute or disagreement with the Company.
4Mr. James Denny currently serves as Lead Independent Director and will continue until his retirement.
5A successor Lead Independent Director is expected to be appointed in May 2013.

GILEAD SCIENCES, INC. 8-K Report, Executive Changes (Jan 31, 2013)

Summary

Key Highlights

Frequently Asked Questions